Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $96.96 USD
Change Today -0.34 / -0.35%
Volume 862.1K
MJN On Other Exchanges
As of 8:04 PM 06/1/15 All times are local (Market data is delayed by at least 15 minutes).

mead johnson nutrition co (MJN) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/27/15 - $105.45
52 Week Low
06/12/14 - $85.89
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

mead johnson nutrition co (MJN) Details

Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children’s nutrition, and other nutritional products. It offers routine infant formula products as a breast milk substitute for healthy infants for the use as the infant’s source of nutrition, as well as a supplement to breastfeeding under the Enfamil Premium, Enfapro Premium, Enfamil A+, and Enfalac A+ names; and solutions products to address common feeding tolerance problems, including spit-up, fussiness, gas, and lactose intolerance under the Enfamil Gentlease and Enfamil A.R names. The company also provides specialty formula products, including formulas for addressing various conditions or special medical needs, such as cow’s milk protein and multiple other food allergies, premature and low birth weight infants, and premature babies at home, as well as produces medical foods for nutritional management of individuals under the Nutramigen, Puramino, Enfamil Premature, and EnfaCare. In addition, it offers children’s nutrition products comprising products for meeting children’s nutritional needs at toddlers and older children stage, as well as offer milk modifiers under the Enfagrow, ChocoMilk, and Cal-C-Tose names; a range of other products, including pre-natal and post-natal nutritional supplements for expectant and nursing mothers under the Expecta and EnfaMama names; and pediatric vitamin under the Enfamil Poly-Vi-Sol name, as well as multivitamins and iron supplements. The company sells its products to mothers, health care professionals, and retailers in approximately 50 countries in North America, Europe, Asia, and Latin America. Mead Johnson Nutrition Company was founded in 1905 and is headquartered in Glenview, Illinois.

7,700 Employees
Last Reported Date: 02/27/15
Founded in 1905

mead johnson nutrition co (MJN) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $1.0M
Interim Chief Financial Officer, Senior Vice ...
Total Annual Compensation: $551.0K
Senior Vice President of Technical Operations
Total Annual Compensation: $407.5K
Compensation as of Fiscal Year 2014.

mead johnson nutrition co (MJN) Key Developments

Mead Johnson Nutrition Company Announces Executive Changes

Mead Johnson Nutrition Company announced that effective as of May 18, 2015, Mr. Tom De Weerdt no longer serves as the company's Vice President and Corporate Controller. As of May 18, 2015, the company appointed Mr. Charles M. Urbain, the company's Senior Vice President and Interim Chief Financial Officer, to serve as the company's Interim Controller until Mr. De Weerdt's successor is appointed. In his capacity as Interim Controller, Mr. Urbain shall be the company's chief accounting officer. Mr. Urbain, age 61, has been the company's Interim Chief Financial Officer since March 13, 2015. He had served as Senior Vice President, Stakeholder Relations and Chief Development Officer since January 2012, which role included leadership of the company's global human resources function.

Mead Johnson Nutrition Company Presents at Citi 2015 Global Consumer Conference, May-28-2015 12:00 PM

Mead Johnson Nutrition Company Presents at Citi 2015 Global Consumer Conference, May-28-2015 12:00 PM. Venue: The Plaza, a Fairmont Managed Hotel, Fifth Avenue at Central Park South, New York, NY 10019, United States. Speakers: Peter Kasper Jakobsen, Chief Executive Officer, President and Director.

Mead Johnson Nutrition Company Announces Unaudited Consolidated Financial Results for the First Quarter Ended March 31, 2015; Reaffirms Earnings Outlook for 2015

Mead Johnson Nutrition Company announced unaudited consolidated financial results for the first quarter ended March 31, 2015. First quarter sales of $1,094.4 million were down from $1,113.3 million in the prior year quarter. Constant dollar sales increased slightly more than 3%, driven by pricing. In aggregate, volume was flat due primarily to tough prior year comparisons in the U.S. and China businesses. Net earnings attributable to shareholders totaled $207.4 million, or $1.02 per diluted share, in the first quarter of 2015, compared to $202.4 million, or $1.00 per diluted share, in the prior year quarter. On a non-GAAP basis, net earnings attributable to shareholders totaled $222.2 million, or $1.09 per diluted share, for the first quarter of 2015, compared to $206.1 million, or $1.02 per diluted share, for the same quarter a year ago. Operating cash flow was $274.5 million in the quarter ended March 31, 2015 compared to $197.6 million in the prior year quarter. With similar earnings in both years, the change is due primarily to inventory increases in 2014. Earnings before tax was $271.4 million compared to $278.8 million a year ago. Payment for capital expenditure was $46.1 million compared to $63.1 million a year ago. The company reiterates 2015 non-GAAP EPS in the range of $3.90 to $4.00. The company anticipates revenue growth around 7% in constant dollars with growth largely in the second half of the year as new initiatives are launched. The company currently expects the impact of adverse foreign currency translation to be approximately 5%, leading to reported sales growth of approximately 2%. Specified items are currently expected to be $0.11 per diluted share excluding any mark-to-market pension adjustments. As a result, full year GAAP EPS is expected to be in the range of $3.79 to $3.89.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MJN:US $96.96 USD -0.34

MJN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Biostime International Holdings Ltd $27.55 HKD -4.15
Inner Mongolia Yili Industrial Group Co Ltd CNY20.98 CNY +0.21
Perrigo Co PLC $192.99 USD +2.69
Hain Celestial Group Inc/The $62.91 USD -0.36
Yakult Honsha Co Ltd ¥6,950 JPY +100.00
View Industry Companies

Industry Analysis


Industry Average

Valuation MJN Industry Range
Price/Earnings 27.3x
Price/Sales 4.5x
Price/Book 29.5x
Price/Cash Flow 27.2x
TEV/Sales 3.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEAD JOHNSON NUTRITION CO, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at